Early postoperative changes of sphingomyelins and ceramides after laparoscopic sleeve gastrectomy

[1]  E. Ravussin,et al.  Skeletal muscle ceramides and daily fat oxidation in obesity and diabetes. , 2018, Metabolism: clinical and experimental.

[2]  M. Aslan,et al.  Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients. , 2018, Lipids.

[3]  O. Santos,et al.  Self-Regulation of Weight After Sleeve Gastrectomy , 2018, Behavior modification.

[4]  Yu Cao,et al.  The sphingomyelin synthase family: proteins, diseases, and inhibitors , 2017, Biological chemistry.

[5]  M. Aslan,et al.  Inhibition of neutral sphingomyelinase decreases elevated levels of nitrative and oxidative stress markers in liver ischemia–reperfusion injury , 2017, Redox report : communications in free radical research.

[6]  Hannah Jia Hui Ng,et al.  Early weight loss after laparoscopic sleeve gastrectomy predicts midterm weight loss in morbidly obese Asians. , 2016, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[7]  J. Ussher,et al.  Targeting ceramide metabolism in obesity. , 2016, American journal of physiology. Endocrinology and metabolism.

[8]  H. Car,et al.  Regulation of sphingomyelin metabolism , 2016, Pharmacological reports : PR.

[9]  A. Mureşan,et al.  Effects of sleeve gastrectomy on insulin resistance , 2016, Clujul medical.

[10]  J. Ryder,et al.  Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesity , 2016, International Journal of Obesity.

[11]  G. Shulman,et al.  A Role of the Inflammasome in the Low Storage Capacity of the Abdominal Subcutaneous Adipose Tissue in Obese Adolescents , 2015, Diabetes.

[12]  Y. Hannun,et al.  Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death* , 2015, Journal of Biological Chemistry.

[13]  Karen Winters,et al.  Overweight and Obesity: Prevalence, Consequences, and Causes of a Growing Public Health Problem , 2015, Current Obesity Reports.

[14]  E. Livingston,et al.  Long-term follow-up after bariatric surgery: a systematic review. , 2014, JAMA.

[15]  A. Futerman,et al.  Ceramide synthases as potential targets for therapeutic intervention in human diseases. , 2014, Biochimica et biophysica acta.

[16]  B. Kingwell,et al.  Plasma Sphingosine-1-Phosphate Is Elevated in Obesity , 2013, PloS one.

[17]  M. Aslan,et al.  Early Postoperative Changes of HDL Subfraction Profile and HDL-Associated Enzymes After Laparoscopic Sleeve Gastrectomy , 2013, Obesity Surgery.

[18]  J. Horowitz,et al.  Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide , 2012, Diabetologia.

[19]  M. Górska,et al.  Ceramide metabolism is affected by obesity and diabetes in human adipose tissue , 2012, Journal of cellular physiology.

[20]  P. Schauer,et al.  Gastric Bypass Surgery Reduces Plasma Ceramide Subspecies and Improves Insulin Sensitivity in Severely Obese Patients , 2011, Obesity.

[21]  Y. Hannun,et al.  Many Ceramides* , 2011, The Journal of Biological Chemistry.

[22]  N. Basso,et al.  First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis , 2011, Surgical Endoscopy.

[23]  M. Gagner,et al.  Changes in Lipid Profiles in Morbidly Obese Patients After Laparoscopic Sleeve Gastrectomy (LSG) , 2011, Obesity surgery.

[24]  Y. Hannun,et al.  Regulated Secretion of Acid Sphingomyelinase , 2010, The Journal of Biological Chemistry.

[25]  K. Petersen,et al.  Lipid-induced insulin resistance: unravelling the mechanism , 2010, The Lancet.

[26]  Arya M. Sharma,et al.  A Review of Laparoscopic Sleeve Gastrectomy for Morbid Obesity , 2010, Obesity surgery.

[27]  R. DeFronzo,et al.  Plasma Ceramides Are Elevated in Obese Subjects With Type 2 Diabetes and Correlate With the Severity of Insulin Resistance , 2009, Diabetes.

[28]  Henry Buchwald,et al.  Interdisciplinary European Guidelines on Surgery of Severe Obesity , 2008, Obesity Facts.

[29]  S. Summers,et al.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. , 2008, Endocrine reviews.

[30]  M. Birnbaum,et al.  Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. , 2007, Cell metabolism.

[31]  H Buchwald,et al.  Inter-disciplinary European guidelines on surgery of severe obesity , 2007, International Journal of Obesity.

[32]  Y. Hannun,et al.  Altered Adipose and Plasma Sphingolipid Metabolism in Obesity , 2006, Diabetes.

[33]  M. Shields,et al.  Trends in adult obesity. , 2006, Health reports.

[34]  T. Veenstra,et al.  Phosphorylation of Ser24 in the Pleckstrin Homology Domain of Insulin Receptor Substrate-1 by Mouse Pelle-like Kinase/Interleukin-1 Receptor-associated Kinase , 2005, Journal of Biological Chemistry.

[35]  J. Levy,et al.  Use and abuse of HOMA modeling. , 2004, Diabetes care.

[36]  Alfred H. Merrill,et al.  De Novo Sphingolipid Biosynthesis: A Necessary, but Dangerous, Pathway* , 2002, The Journal of Biological Chemistry.

[37]  M. Lorenzo,et al.  Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. , 2001, Diabetes.

[38]  I. Batty,et al.  Ceramide impairs the insulin-dependent membrane recruitment of Protein Kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells , 2001, Diabetologia.

[39]  C. Schmitz‐Peiffer,et al.  Ceramide Generation Is Sufficient to Account for the Inhibition of the Insulin-stimulated PKB Pathway in C2C12 Skeletal Muscle Cells Pretreated with Palmitate* , 1999, The Journal of Biological Chemistry.

[40]  A. Brogi,et al.  Induction of intracellular ceramide by interleukin‐1β in oligodendrocytes , 1997 .

[41]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[42]  A. Nilsson,et al.  The presence of spingomyelin- and ceramide-cleaving enzymes in the small intestinal tract. , 1969, Biochimica et biophysica acta.

[43]  A. Gomez-Muñoz,et al.  Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate. , 2016, Progress in lipid research.

[44]  N. Basso,et al.  Early Postoperative Insulin-Resistance Changes After Sleeve Gastrectomy , 2010, Obesity surgery.

[45]  S. Summers,et al.  Ceramides in insulin resistance and lipotoxicity. , 2006, Progress in lipid research.

[46]  R. DeFronzo,et al.  Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. , 2004, Diabetes.

[47]  A. Brogi,et al.  Induction of intracellular ceramide by interleukin-1 beta in oligodendrocytes. , 1997, Journal of cellular biochemistry.